心房颤动合并冠状动脉慢血流的机制研究进展

doi:10.16138/j.1673-6087.2026.03.14

内科理论与实践 ›› 2026, Vol. 21 ›› Issue (03): 270-276.doi: 10.16138/j.1673-6087.2026.03.14

心房颤动合并冠状动脉慢血流的机制研究进展

柴宇燕¹(), 康启帆¹, 白雪莲¹, 李志梅¹, 魏玮¹, 凌天佑²()

1.张掖市第二人民医院心内科，甘肃张掖　734000
2.上海交通大学医学院附属瑞金医院心内科，上海　200025

收稿日期:2026-03-16 修回日期:2026-04-28 接受日期:2026-07-02 出版日期:2026-06-25 发布日期:2026-08-19
通讯作者: 凌天佑 E-mail：lty0919@hotmail.com
作者简介:作者贡献/Authors’ Contributions柴宇燕负责撰写初稿与修改；康启帆负责文献检索；白雪莲负责文献整理；李志梅负责编辑；魏玮负责项目管理；凌天佑负审阅及研究实施。
基金资助:
上海交通大学教育发展基金项目(TQ-0133-00-0062)

Research progress on the mechanisms of atrial fibrillation complicated with coronary slow flow

CHAI Yuyan¹(), KANG Qifan¹, BAI Xuelian¹, LI Zhimei¹, WEI Wei¹, LING Tianyou²()

1. Department of Cardiology, Zhangye Second People's Hospital, Zhangye 734000, China
2. Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received:2026-03-16 Revised:2026-04-28 Accepted:2026-07-02 Online:2026-06-25 Published:2026-08-19

摘要/Abstract

摘要：

冠状动脉慢血流（coronary slow flow，CSF）指冠状动脉造影未见明显狭窄病变，但远端血流灌注延迟的特殊临床现象，与动脉粥样硬化、炎症反应、内皮功能障碍密切相关。心房颤动（atrial fibrillation，AF）是常见心律失常，与CSF存在一定临床关联，AF患者中CSF发生率明显高于窦性心律人群。本文从流行病学、血流动力学及病理生理学3个层面梳理AF与CSF的关联，认为微循环调节障碍是连接二者的重要病理环节，主要表现为微血管内皮功能损伤与血液流变学异常，并阐述宏观血流动力学紊乱如何通过生物力学信号逐渐演变为微循环结构性重塑。明确内皮功能障碍与血液流变学异常在AF合并CSF中的相互作用，为临床早期干预提供理论依据。

关键词: 心房颤动, 冠状动脉慢血流, 冠状动脉微循环障碍, 内皮功能障碍, 血液流变学

Abstract:

Coronary slow flow (CSF) refers to a distinct clinical phenomenon in which coronary angiography reveals no obvious stenotic lesions, yet distal blood flow perfusion is delayed. It is closely associated with atherosclerosis, inflammatory responses, and endothelial dysfunction. Atrial fibrillation (AF), a common cardiac arrhythmia, exhibits a certain clinical correlation with CSF: the incidence of CSF is notably higher in patients with AF than in those with sinus rhythm. This article reviews the associations between AF and CSF at 3 levels — epidemiological, hemodynamic, and pathophysiological — and identifies microcirculatory dysregulation as an essential pathological link connecting the two conditions, primarily manifested as microvascular endothelial dysfunction and hemorheological abnormalities. It also elaborates on how macroscopic hemodynamic disturbances gradually evolve into structural microcirculatory remodeling through biomechanical signals. By clarifying the interaction between endothelial dysfunction and hemorheological abnormalities in AF complicated with CSF, this review aims to provide a theoretical basis for early clinical intervention.

Key words: atrial fibrillation, coronary slow flow, coronary microcirculatory dysfunction, endothelial dysfunction, hemorheology

中图分类号:

柴宇燕, 康启帆, 白雪莲, 李志梅, 魏玮, 凌天佑. 心房颤动合并冠状动脉慢血流的机制研究进展[J]. 内科理论与实践, 2026, 21(03): 270-276.

CHAI Yuyan, KANG Qifan, BAI Xuelian, LI Zhimei, WEI Wei, LING Tianyou. Research progress on the mechanisms of atrial fibrillation complicated with coronary slow flow[J]. Journal of Internal Medicine Concepts & Practice, 2026, 21(03): 270-276.

图/表 1

参考文献 39

[1]	Wen ZG, Long JJ, Wang Y. Association between inflammatory burden index and coronary slow flow phenomenon in patients with chest pain and no obstructive coronary arteries[J]. BMC Cardiovasc Disord, 2024, 24(1): 595.
[2]	尚夕宁, 孙鸣宇. 导管消融联合经皮左心耳封堵“一站式”手术治疗心房颤动发展现状[J]. 临床军医杂志, 2025, 53(7): 764-767.
	Shang XN, Sun MY. Current status of combined catheter ablation and percutaneous left atrial appendage closure as a one-stop procedure for atrial fibrillation[J]. Clin J Med Off, 2025, 53(7): 764-767.
[3]	邹祎, 余泽洪, 谭文锋, 等. 冠状动脉慢血流与阵发性心房颤动的关系探讨[J]. 中国实用医药, 2007, 2(7): 5-7.
	Zou Y, Yu ZH, Tan WF, et al. Relationship between paroxysmal atrial fibrillation and coronary slow flow[J]. China Pract Med, 2007, 2(7): 5-7.
[4]	Luo C, Wu X, Huang Z, et al. Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation[J]. Int J Cardiol, 2013, 167(4): 1176-1180.
[5]	Gao YF, Chen Y, Wang CJ, et al. Atrial fibrillation episode status and incidence of coronary slow flow: a propensity score-matched analysis[J]. Front Cardiovasc Med, 2023, 10: 1047748.
[6]	刘刚, 刘超, 刘坤申, 等. 房颤低能量电复律及维持窦性心律的研究[J]. 医学研究杂志, 2007, 36(4): 65.
	Liu G, Liu C, Liu KS, et al. Research on low-energy electrical cardioversion and maintenance of sinus rhythm in atrial fibrillation[J]. J Med Res, 2007, 36(4): 65.
[7]	孟杰, 王萍. 心房纤颤对老年冠心病患者心功能的影响[J]. 中原医刊, 2005, 32(4): 2-3.
	Meng J, Wang P. Effect of atrial fibrillation on cardiac function in elderly patients with coronary heart disease[J]. Cent Plains Med J, 2005, 32(4): 2-3.
[8]	Kochiadakis GE, Kallergis EM. Impact of atrial fibrillation on coronary blood flow: a systematic review[J]. J Atr Fibrillation, 2012, 5(3): 458.
[9]	Skalidis EI, Hamilos MI, Karalis IK, et al. Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation[J]. J Am Coll Cardiol, 2008, 51(21): 2053-2057. doi: 10.1016/j.jacc.2008.01.055
[10]	李金轶, 梁桂琤, 王世荣, 等. 心房颤动患者左心房血清炎性因子和血管内皮损伤标志物水平变化与血栓的相关性研究[J]. 中国全科医学, 2022, 25(32): 4018-4022.
	Li JY, Liang GC, Wang SR, et al. Correlation of markers of inflammation and endothelial injury with thrombosis in left atrium in patients with atrial fibrillation[J]. Chin Gen Pract, 2022, 25(32): 4018-4022.
[11]	中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会. 糖尿病心肌病病证结合诊疗指南（2021-12-31）[J]. 世界中医药, 2022, 17(12): 1641-1653. doi: 10.3969/j.issn.1673-7202.2022.12.001
	Endocrinology and Metabolism Professional Committee of Integrated Traditional Chinese and Western Medicine Physician Branch of Chinese Medical Doctor Association. Guideline for the diagnosis and treatment of diabetic cardiomyopathy with integration of disease and syndrome (2021-12-31)[J]. World Chin Med, 2022, 17(12): 1641-1653. doi: 10.3969/j.issn.1673-7202.2022.12.001
[12]	Lin J, Lin H, Xu Z, et al. Angiogenesis in atrial fibrillation: a literature review[J]. Biomedicines, 2025, 13(6): 1399. doi: 10.3390/biomedicines13061399
[13]	秦亚录, 庄光彤, 黄爱玲, 等. 生长激素释放肽-肥胖抑制素对心房颤动患者左房重构的影响机制探讨[J]. 实用医院临床杂志, 2024, 21(4): 89-92.
	Qin YL, Zhuang GT, Huang AL, et al. Study on the mechanism of the influence of ghrelin-obestatin on left atrial remodeling in patients with atrial fibrillation[J]. Pract J Clin Med, 2024, 21(4): 89-92.
[14]	冯光玲, 毛文锋, 郅强, 等. 基于AngII-NO_x-ROS信号通路探索黄杨宁对心房颤动犬氧化应激的影响[J]. 中国比较医学杂志, 2023, 33(3): 17-23.
	Feng GL, Mao WF, Zhi Q, et al. Effect of Huangyangning on oxidative stress in dogs with atrial fibrillation via the AngII-NO_x-ROS signaling pathway[J]. Chin J Comp Med, 2023, 33(3): 17-23.
[15]	Shin SY, Na JO, Lim HE, et al. Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation[J]. J Cardiovasc Electrophysiol, 2011, 22(4): 376-382.
[16]	黄克, 左可可, 顾宁. 基于血管内皮功能探讨冠状动脉微循环障碍“虚气留滞”病机的科学内涵[J]. 辽宁中医药大学学报, 2025, 27(7): 44-49. doi: 10.13194/j.issn.1673-842X.2025.07.008
	Huang K, Zuo KK, Gu N. Discussing the scientific connotation of coronary microcirculation dysfunction “stagnation of virtual qi” based on vascular endothelial function[J]. J Liaoning Univ Tradit Chin Med, 2025, 27(7): 44-49. doi: 10.13194/j.issn.1673-842X.2025.07.008
[17]	王敏, 周志兰. 尼可地尔联合单硝酸异山梨酯治疗稳定型心绞痛疗效及对内皮功能、炎症反应的影响[J]. 中南医学科学杂志, 2025, 53(1): 106-109. doi: 10.15972/j.cnki.43-1509/r.2025.01.026
	Wang M, Zhou ZL. Efficacy of nicorandil combined with isosorbide mononitrate in the treatment of stable angina pectoris and its effects on endothelial function and inflammation[J]. Med Sci J Cent South China, 2025, 53(1): 106-109. doi: 10.15972/j.cnki.43-1509/r.2025.01.026
[18]	Plaatjie ON, van Furth AMT, Solomons R, et al. CSF carnitine is a potential biomarker in paediatric tuberculous meningitis[J]. Sci Rep, 2025, 15(1): 29366. doi: 10.1038/s41598-025-15000-0
[19]	陈治奎, 姜庆军, 胡万英, 等. 冠状动脉慢血流的临床特点及相关因素的研究[J]. 中国现代医生, 2015, 53(18): 26-29.
	Chen ZK, Jiang QJ, Hu WY, et al. The clinical characteristics and risk factors of coronary slow flow phenomenon[J]. China Mod Doctor, 2015, 53(18): 26-29.
[20]	郝亚逢, 李远, 刘俊法, 等. 冠状动脉慢血流的临床特点及其与血管内皮功能的相关性研究[J]. 海南医学, 2017, 28(2): 200-202.
	Hao YF, Li Y, Liu JF, et al. Clinical features of coronary slow flow and its correlation with vascular endothelial function[J]. Hainan Med J, 2017, 28(2): 200-202.
[21]	Obeagu EI. Cytokine storm and microvascular fate: mechanistic insights into endothelial injury in thrombotic microangiopathies[J]. Ann Med Surg, 2025, 87(9): 5912-5917.
[22]	佟晶, 卑贵光, 杨本强. 内皮功能障碍与冠状动脉慢血流关系研究进展[J]. 临床军医杂志, 2024, 52(4): 433-436.
	Tong J, Bei GG, Yang BQ. Research progress on the relationship between endothelial dysfunction and coronary slow flow[J]. Clin J Med Off, 2024, 52(4): 433-436.
[23]	张晓伟, 宋艳梅, 袁铭, 等. 二甲双胍激活AMPK信号通路促进糖尿病大鼠线粒体合成拮抗心房颤动的分子电生理机制[J]. 中华心律失常学杂志, 2024, 28(6): 529-538.
	Zhang XW, Song YM, Yuan M, et al. Molecular electrophysiological mechanism of metformin activation of adenosine 5’-monophate activated protein kinase signaling pathway to promote mitochondrial synthesis in diabetic rats against atrial fibrillation[J]. Chin J Card Arrhythm, 2024, 28(6): 529-538.
[24]	王凌雁, 曲辅政. 肾功能指标、CRP、ET-1与慢性心力衰竭患者发生房颤的相关性分析[J]. 医师在线, 2024, 14(1): 39-42.
	Wang LY, Qu FZ. Correlation analysis between renal function indexes combined with CRP and ET-1 and the incidence of atrial fibrillation in patients with chronic heart failure[J]. Physician Online, 2024, 14(1): 39-42.
[25]	刘凡凡, 张越强, 白盼盼, 等. 射血分数保留型心力衰竭合并心房颤动的研究进展[J]. 安徽医药, 2024, 28(4): 654-659.
	Liu FF, Zhang YQ, Bai PP, et al. Research progress of heart failure with preserved ejection fraction complicated with atrial fibrillation[J]. Anhui Med Pharm J, 2024, 28(4): 654-659.
[26]	吴章明, 熊尚全, 李翠云, 等. 冠状动脉慢血流患者血栓弹力图特点分析[J]. 实用中西医结合临床, 2022, 22(5): 7-11. doi: 10.13638/j.issn.1671-4040.2022.05.002
	Wu ZM, Xiong SQ, Li CY, et al. Analysis of the characteristics of thromboelastography in patients with coronary slow flow[J]. Pract Clin J Integr Tradit Chin West Med, 2022, 22(5): 7-11. doi: 10.13638/j.issn.1671-4040.2022.05.002
[27]	潘忠海. PCI术后冠心病伴房颤患者三联抗栓疗效及不良心血管风险剖析[J]. 现代医学研究（香港）, 2025 2 74-76.
	Pan ZH. Analysis of the efficacy and adverse cardiovascular risk of triple antithrombotic therapy in patients with coronary heart disease and atrial fibrillation after PCI[J]. Modern Medical Research, 2025 2 74-76.
[28]	王华, 杨杰孚, 包承鑫, 等. 心房颤动患者高凝状态研究[J]. 临床荟萃, 2006, 21(7): 461-464.
	Wang H, Yang JF, Bao CX, et al. Study of hypercoagulation state in patients with atrial fibrillation[J]. Clin Focus, 2006, 21(7): 461-464.
[29]	张梦玮, 熊政, 仲丹, 等. 冠状动脉CT血管成像对冠心病合并心房颤动患者的预测价值[J]. 临床心血管病杂志, 2025, 41(6): 448-452.
	Zhang MW, Xiong Z, Zhong D, et al. Predictive value of coronary CTA in patients with coronary heart disease combined with atrial fibrillation[J]. J Clin Cardiol, 2025, 41(6): 448-452.
[30]	温冬梅. 增强型体外反搏在冠脉慢血流患者中的应用效果及对内皮功能和血流改善效应的影响[J]. 医学理论与实践, 2025, 38(6): 949-951. doi: 10.19381/j.issn.1001-7585.2025.06.012
	Wen DM. Application effect of enhanced external counterpulsation in patients with coronary slow flow and its impact on endothelial function and blood flow improvement[J]. J Med Theory Pract, 2025, 38(6): 949-951. doi: 10.19381/j.issn.1001-7585.2025.06.012
[31]	郭衍楷, 闫长舜, 吴敏, 等. 冠状动脉慢血流发生的危险因素分析及预测列线图构建[J]. 山东医药, 2024, 64(33): 19-24.
	Guo YK, Yan CS, Wu M, et al. Risk factors for coronary slow flow phenomenon and construction of a predictive nomogram[J]. Shandong Med J, 2024, 64(33): 19-24.
[32]	魏珂乐, 袁义燕, 詹雯. 冠状动脉慢血流患者的动态心电图特点及其影响因素[J]. 实用心电与临床诊疗, 2025, 34(6): 830-834. doi: 10.13308/j.issn.2097-5716.2025.06.009
	Wei KL, Yuan YY, Zhan W. Ambulatory electrocardiography characteristics of patients with coronary slow flow and its influencing factors[J]. Pract Electrocardiol Clin Treat, 2025, 34(6): 830-834. doi: 10.13308/j.issn.2097-5716.2025.06.009
[33]	吴宝全, 刘晓霞. 血小板反应性、ROCK1联合心电图表现对老年PCI后慢血流/无复流预测能力[J]. 昆明医科大学学报, 2025, 46(4): 150-156. doi: 10.12259/j.issn.2095-610X.S20250420
	Wu BQ, Liu XX. Predictive ability of platelet reactivity, ROCK1 combined with electrocardiogram findings for slow blood flow/no reflow in elderly patients after PCI[J]. J Kunming Med Univ, 2025, 46(4): 150-156. doi: 10.12259/j.issn.2095-610X.S20250420
[34]	陈晖. 冠状动脉慢血流现象的临床影响因素分析[J]. 中国当代医药, 2015, 22(16): 53-55.
	Chen H. Clinical risk factor analysis of slow coronary flow phenomenon[J]. China Mod Med, 2015, 22(16): 53-55.
[35]	刘玉洁. 华法林对心房颤动患者凝血功能、血小板参数及血液流变学的影响研究[J]. 临床合理用药杂志, 2021, 14(33): 11-14.
	Liu YJ. Effect of warfarin on coagulation function, platelet parameters and hemorheology in patients with atrial fibrillation[J]. Chin J Clin Ration Drug Use, 2021, 14(33): 11-14.
[36]	刘用, 肖狄, 牛超峰, 等. 冠状动脉慢血流的影响因素及文献计量研究[J]. 中国临床研究, 2023, 36(7): 1054-1059.
	Liu Y, Xiao D, Niu CF, et al. Influencing factors and bibliometric study of coronary slow flow[J]. Chin J Clin Res, 2023, 36(7): 1054-1059.
[37]	郭珊珊, 韩拓, 王洪涛, 等. 高尿酸血症与心房颤动相关性及治疗进展[J]. 国际心血管病杂志, 2025, 52(1): 1-4.
	Guo SS, Han T, Wang HT, et al. Relation of hyperuricemia with atrial fibrillation and its therapeutic implications[J]. Int J Cardiovasc Dis, 2025, 52(1): 1-4.
[38]	尚玲慧. 血清胆红素、蛋白与尿酸检测对冠心病患者临床检验的价值探析[J]. 医学信息, 2025, 38(12): 140-143.
	Shang LH. Value of serum bilirubin, protein and uric acid detection in clinical examination of patients with coronary heart disease[J]. Med Inf, 2025, 38(12): 140-143.
[39]	张林叶, 柏战, 王宗方, 等. 冠状动脉慢血流患者发生心房纤颤与NT-proBNP关系[J]. 疑难病杂志, 2019, 18(7): 661-664.
	Zhang LY, Bai Z, Wang ZF, et al. Relationship between atrial fibrillation and NT-proBNP in patients with coronary slow flow[J]. Chin J Difficult Complicat Cases, 2019, 18(7): 661-664.

心房颤动合并冠状动脉慢血流的机制研究进展

Research progress on the mechanisms of atrial fibrillation complicated with coronary slow flow

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 39

相关文章 15

编辑推荐

Metrics

本文评价

[1]	卫越, 包阳扬, 罗庆志, 谢运, 林长坚, 张凝, 金奇, 凌天佑, 吴立群. 冷冻球囊消融与电复律治疗初发持续性心房颤动疗效及安全性比较[J]. 内科理论与实践, 2026, 21(03): 211-216.
[2]	陈昱竹, 陈柯萍. Bachmann束起搏研究进展[J]. 内科理论与实践, 2026, 21(03): 265-269.
[3]	夏盼盼, 曹宾, 孙育民. 《中国心房颤动管理指南（2025）》解读[J]. 内科理论与实践, 2026, 21(03): 205-210.
[4]	陈梁国, 邓可武, 刘越, 钟鹏, 白英. 甘油三酯-葡萄糖指数与心房颤动患者发生急性心肌梗死风险的关系[J]. 内科理论与实践, 2025, 20(06): 435-439.
[5]	靳正逸, 刘齐龙, 胡佳琪, 徐霞, 高洁. 高尿酸血症与心血管疾病关系的研究进展[J]. 内科理论与实践, 2025, 20(04): 334-339.
[6]	罗晓颖, 章安迪, 许燕, 吴立群, 戚文航. 缺血性心力衰竭患者N端脑钠肽前体与新发房颤的相关性研究[J]. 诊断学理论与实践, 2024, 23(03): 313-317.
[7]	孙以亚, 罗庆志, 金奇, 吴立群. 导管消融治疗心房颤动合并射血分数保留型心力衰竭患者的临床进展[J]. 内科理论与实践, 2024, 19(03): 188-192.
[8]	李晴, 郑朝霞, 罗静慧, 李莉, 牛福英. 残粒胆固醇、同型半胱氨酸预测老年急性心肌梗死患者新发心房颤动的价值[J]. 内科理论与实践, 2024, 19(01): 68-71.
[9]	陆林, 代杨, 王晓群, 吴立群, 张瑞岩, 沈卫峰. 心血管转化研究的若干进展[J]. 内科理论与实践, 2022, 17(05): 369-372.
[10]	吴立群. 大道至简——肺静脉隔离新技术[J]. 内科理论与实践, 2022, 17(05): 357-359.
[11]	张芝, 汤学超, 黄新苗, 秦永文. 脉冲电场消融在心房颤动中的应用[J]. 内科理论与实践, 2022, 17(05): 400-404.
[12]	费镇涛, 陈牧, 李毅刚. 心房颤动导管消融后复发机制的研究进展[J]. 内科理论与实践, 2022, 17(05): 396-399.
[13]	尹翔, 郑良荣. 经皮左心耳封堵预防心房颤动卒中的研究进展[J]. 内科理论与实践, 2022, 17(05): 392-395.
[14]	徐敏, 张京岚. 非心脏手术后新发心房颤动患者的相关临床分析[J]. 内科理论与实践, 2022, 17(04): 334-336.
[15]	白英, 刘心遥, 张溪林, 高兆芳, 史旭波, 邓可武. 规范抗凝对心房颤动住院患者预后的影响[J]. 内科理论与实践, 2021, 16(06): 409-412.